Watkin Phoebe L. Yang - 07 May 2026 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Reporting relationship: Director
Issuer ticker: GEHC
Reported as of: 07 May 2026
Net transaction value: +$63,006
SEC form: 4
Accepted by SEC: 11 May 2026, 20:16:07 UTC
Prior SEC filing: 02 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact

Key filing fact

Watkin Phoebe L. Yang filed Form 4 for GE HealthCare Technologies Inc. (GEHC) on 11 May 2026.

Key facts

This page summarizes Watkin Phoebe L. Yang's Form 4 filing for GE HealthCare Technologies Inc. (GEHC).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 11 May 2026, 20:16.

Change

Previous filing in this sequence was filed on 02 Sep 2025.
Current net transaction value: +$63,006.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001940538 Primary reporting owner

Yang Watkin Phoebe L.

Relationship: Director
Address: 500 W. MONROE STREET, CHICAGO
Signature: /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Signature date: 11 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GEHC transaction

Common Stock, par value $0.01 per share

Award

Transaction value
Shares: +3,586
Change %: +39%
Price: $0.000000^*
Shares after: 12,702
Date: 07 May 2026
Ownership: Direct
Footnotes: F1, F2

GEHC transaction

Common Stock, par value $0.01 per share

Purchase

Transaction value: $63,006
Shares: +1,000
Change %: +7.9%
Price: $63.01
Shares after: 13,702
Date: 08 May 2026
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

Footnote F2

Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Footnote F3

The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.